title: Venlafaxine in the treatment of panic disorder.
abstract: Venlafaxine XR is a novel, dual acting SNRI antidepressant, which inhibits both serotonin and norepinephrine reuptake. Controlled trials have demonstrated the efficacy and safety of venlafaxine in the treatment of panic disorder. Generally well tolerated, with side-effects that usually abate with continued treatment, venlafaxine is an important option to the SSRIs for the treatment of patients with panic disorder.
authors.affiliation: START Clinic for the Mood and Anxiety Disorders, 790 Bay, Street-Suite 900, Toronto, ON M5G 1N8, Canada. mkatzman@startclinic.ca
authors.forename: Martin A
authors.initials: MA
authors.lastname: Katzman
authors.forename: Leslie
authors.initials: L
authors.lastname: Jacobs